lifescore Edge · GLP-1 evidence guide
GLP-1 claims need the right product and measure.
Start with the same semaglutide molecule delivered two ways, then ask what substantial weight loss contains. The second half of the guide separates retatrutide's developing trial record from the evidence carried by a compounded preparation.
Two places to start
Follow the claim, then test the transfer.
Does oral semaglutide match injectable semaglutide for weight loss?
The approved 25 mg tablet and 2.4 mg weekly injection produced close weight loss in separate trials, but no head-to-head proves equivalence.
Read the evidence
Do GLP-1 drugs cause disproportionate muscle loss?
Human studies show real lean-mass loss as fat falls more, but direct muscle and function evidence is too thin to prove disproportionate wasting.
Read the evidence
What does human evidence show about retatrutide?
Randomized trials show large weight and glucose reductions, but most Phase 3 obesity results lack full publication and no retatrutide product is approved.
Read the evidence
Do compounded GLP-1 drugs have the same human evidence?
Only 94 people and one self-experimenter received these products in indexed studies; all authors of the sole cohort were paid by its wellness chain.
Read the evidenceBefore the result
Keep three boundaries visible.
Route
The same active substance can have different administration conditions, exposure variability and approved doses.
See the evidenceMeasurement
A decline in DXA lean mass is not automatically lost functional skeletal muscle.
See the evidenceProduct
Trial results belong to the product that was tested, not automatically to another vial carrying a related name.
See the evidenceEquivalence
A shared active ingredient is not itself a study showing that two finished preparations perform the same way.
See the evidenceCoverage boundary
Current coverage is deliberately bounded to semaglutide delivery, muscle-loss interpretation, retatrutide evidence and compounded-product evidence. This is not a complete drug guide or individualized medical advice.
Edge delivery
Get new Edge articles in your inbox.
Evidence-led insights, delivered when published.